On October 15, 2021, Walmart and Transcarent announced that they will be working together as go-to-market partners for self-insured employers across the country. Their agreement allows Transcarent, which offers employers and their dependents a new, different, and better health and care experience, to share Walmart’s everyday low cost on pharmaceuticals and other services with self-insured employers and their employees for the first time. Wilson Sonsini Goodrich & Rosati advised Transcarent on the transaction.

The collaboration makes it easier for millions of employees and the families of self-insured employers to access high-value care—no matter where they live—at affordable prices. This new offering will allow employers of all sizes to leverage Walmart’s health care size and scale to more easily provide their employees convenient care and cost-effective health and wellness options.

“Together, Walmart and Transcarent have the scale and innovation required to transform the way health and care are delivered and paid for across the nation, regardless of a person’s economic or geographic situation,” said Glen Tullman, chief executive officer of Transcarent. “Transcarent is putting employers and employees back in charge of their health and care. Employees can trust that Transcarent will focus on value and quality first, provide clear and unbiased information, offer a full range of choices, and share the rewards with employees that their better health decisions generate.”

The Wilson Sonsini team that advised Transcarent on the transaction includes technology transactions partner Chris Paniewski and Of Counsel Scott McKinney and corporate partner Mark Baudler and associate Jonathan Chan.

For more information, please see the companies’ joint press release.